Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Ravi Kishore Narra MD

Ravi Kishore Narra MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Medicine Hematology Oncology

View Curriculum Vitae

Publications (23)

  • Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability. (Mohan M, Danziger N, Akhtar OS, Narra R, Pasquini MC, Radhakrishnan S, Dhakal B, D'Souza A, Lin D, Ho C, Kurzrock R) Blood Adv 2026 Feb 24;10(4):1400-1404 PMID: 41733946 SCOPUS ID: 2-s2.0-105030120191 02/24/2026    
  • Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability. (Mohan M, Danziger N, Akhtar OS, Narra R, Pasquini MC, Radhakrishnan S, Dhakal B, D'Souza A, Lin D, Ho C, Kurzrock R) Blood Adv 2026 Feb 24;10(4):1400-1404 PMID: 41411484 PMCID: PMC12927052 SCOPUS ID: 2-s2.0-105030120191 12/18/2025    
  • Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis. (Vandenboom H, Akhtar O, Szabo A, Narra R, Mohan M, D'Souza A, Pasquini M, Dhakal B) Haematologica 2026 Feb 01;111(2):745-750 PMID: 40820831 PMCID: PMC12862333 SCOPUS ID: 2-s2.0-105029263293 08/18/2025    
  • Novel Approaches of Cellular Therapy in Multiple Myeloma: Focus on Chimeric Antigen Receptor T-Cells. (Narra RK, Peshin S, Dhakal B) Acta Haematol 2025;148(3):330-345 PMID: 39733769 SCOPUS ID: 2-s2.0-85217540324 12/30/2024       4 Citations
  • Diagnosing Primary Hemophagocytic Lymphohistiocytosis in an Adult: A Case Report. (Smith KK, Hobbs LM, Narra R) Cureus 2024 Nov;16(11):e72884 PMID: 39624524 PMCID: PMC11610629 12/03/2024    
  • Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma. (Yohay S, Oloyede T, Kim S, Fang X, Dhakal B, Aijaz A, Mohan M, Narra R, Pasquini M, D'Souza A, Hamadani M, Freeman CL, Akhtar OS) Br J Haematol 2024 Dec;205(6):2370-2375 PMID: 39396814 PMCID: PMC12714362 SCOPUS ID: 2-s2.0-85206072300 10/14/2024       3 Citations
  • Racial and Ethnic Disparities in Autologous Hematopoietic Cell Transplantation Utilization in Multiple Myeloma Have Persisted Over Time Even After Referral to a Transplant Center. (Wu JF, Estrada-Merly N, Dhakal B, Mohan M, Narra RK, Pasquini MC, D'Souza A) Transplant Cell Ther 2024 Dec;30(12):1189.e1-1189.e10 PMID: 39277111 PMCID: PMC11736859 SCOPUS ID: 2-s2.0-85205846893 09/15/2024       3 Citations
  • Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study. (Badar T, Narra R, Mims AS, Heckman MG, Shallis RM, Fahad S, Hunter C, Kota V, Othman TA, Jonas B, Desai S, de Camargo Correia GS, Patel A, DuVall AS, Palmisiano N, Curran E, Omer Z, Advani A, Atallah E, Litzow M) Am J Hematol 2024 Dec;99(12):2388-2391 PMID: 39253997 SCOPUS ID: 2-s2.0-85203436363 09/10/2024       6 Citations
  • Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry. (Muthiah C, Narra R, Atallah E, Juan W, Szabo A, Guru Murthy GS) Leuk Res 2024 May;140:107496 PMID: 38547577 SCOPUS ID: 2-s2.0-85188991221 03/29/2024       2 Citations
  • Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. (Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B) Br J Haematol 2024 Mar;204(3):887-891 PMID: 38054558 SCOPUS ID: 2-s2.0-85178904872 12/06/2023       6 Citations
  • The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. (Hammons L, Szabo A, Janardan A, Bhatlapenumarthi V, Annyapu E, Dhakal B, Al Hadidi S, Radhakrishnan SV, Narra R, Bhutani D, Thanendrarajan S, Janz S, Zangari M, Lentzsch S, Van Rhee F, Crescencio JCR, D'Souza A, Chakraborty R, Mohan M, Schinke C) Haematologica 2024 Mar 01;109(3):906-914 PMID: 37646658 PMCID: PMC10905074 SCOPUS ID: 2-s2.0-85178101970 08/30/2023       43 Citations
  • Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma. (Shayeb AM, McManus HD, Urman D, Jani C, Zhang T, Dizman N, Meza L, Sivakumar A, Gan CL, Barata P, Bilen MA, Gao X, Heng D, Pal S, Narra R, Kilari D, Kaymakcalan MD, McGregor B, Choueiri TK, McKay RR) Clin Genitourin Cancer 2023 Feb;21(1):55-62 PMID: 36411184 SCOPUS ID: 2-s2.0-85142487844 11/22/2022       3 Citations
  • Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation. (Ahmed S, Zhao Q, Hanel W, Qazilbash MH, Patel K, Narra R, Kansagra A, Iqbal M, Awan FT, Christian B, Jaglowski SM, Kharfan-Dabaja MA, Hamadani M, Epperla N) Hematol Oncol 2022 Feb;40(1):48-56 PMID: 34763367 SCOPUS ID: 2-s2.0-85119403860 11/12/2021       2 Citations
  • Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation. (Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC) J Surg Res 2020 Nov;255:99-105 PMID: 32543385 SCOPUS ID: 2-s2.0-85086399641 06/17/2020       3 Citations
  • From Theory to Practice: Implementation of Strategies to Reduce Acute Care Visits in Patients With Cancer. (Daly B, Michaelis LC, Sprandio JD, Kapke JT, Narra RK, Malosh E, Zervoudakis A, Holland J, Zablocki M) Am Soc Clin Oncol Educ Book 2020 May;40:85-94 PMID: 32421450 05/19/2020    
  • Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials. (Dhakal B, Narra RK, Giri S, Szabo A, Smunt TL, Ghose S, Pathak LK, Aryal M, Hamadani M, Chhabra S, Janz S, D'Souza A, Hari PN) Cancer 2020 Jun 15;126(12):2791-2801 PMID: 32154922 SCOPUS ID: 2-s2.0-85081273628 03/11/2020       5 Citations
  • Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them. (Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN) Biol Blood Marrow Transplant 2020 Jul;26(7):1288-1297 PMID: 32135202 SCOPUS ID: 2-s2.0-85083636589 03/07/2020       15 Citations
  • Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes. (Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, Shaw BE, Hamadani M, Hari PN) Biol Blood Marrow Transplant 2020 May;26(5):893-901 PMID: 31982543 SCOPUS ID: 2-s2.0-85080146585 01/27/2020       18 Citations
  • Allogenic transplant for non-hodgkin lymphoma (Narra RK, Shah NN) Hematopoietic Cell Transplantation for Malignant Conditions 1 January 2019:209-229 SCOPUS ID: 2-s2.0-85082261875 01/01/2019    
  • Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. (Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M) Biol Blood Marrow Transplant 2019 Apr;25(4):827-833 PMID: 30572109 SCOPUS ID: 2-s2.0-85059680507 12/21/2018       31 Citations
  • Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome. (Vazirabad I, Chhabra S, Nytes J, Mehra V, Narra RK, Szabo A, Jerkins JH, Dhakal B, Hari P, Anderson MW) Biol Blood Marrow Transplant 2019 May;25(5):921-931 PMID: 30537549 SCOPUS ID: 2-s2.0-85060298203 12/12/2018       25 Citations
  • Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation. (Narra RK, Flynn KE, Atallah E) Curr Hematol Malig Rep 2017 Oct;12(5):415-423 PMID: 28944397 PMCID: PMC6045428 SCOPUS ID: 2-s2.0-85029897925 09/26/2017       10 Citations
  • Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 PMID: 26411176 SCOPUS ID: 2-s2.0-84940653430 09/29/2015    
    • Last update: 02/25/2026